These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 22265154)

  • 1. Surgical and visual outcomes of the type I Boston Keratoprosthesis for the management of aniridic fibrosis syndrome in congenital aniridia.
    Bakhtiari P; Chan C; Welder JD; de la Cruz J; Holland EJ; Djalilian AR
    Am J Ophthalmol; 2012 May; 153(5):967-971.e2. PubMed ID: 22265154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A progressive anterior fibrosis syndrome in patients with postsurgical congenital aniridia.
    Tsai JH; Freeman JM; Chan CC; Schwartz GS; Derby EA; Petersen MR; Holland EJ
    Am J Ophthalmol; 2005 Dec; 140(6):1075-9. PubMed ID: 16376654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
    Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
    Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study.
    Akpek EK; Harissi-Dagher M; Petrarca R; Butrus SI; Pineda R; Aquavella JV; Dohlman CH
    Am J Ophthalmol; 2007 Aug; 144(2):227-231. PubMed ID: 17543875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal.
    Hassanaly SI; Talajic JC; Harissi-Dagher M
    Am J Ophthalmol; 2014 Aug; 158(2):270-276.e1. PubMed ID: 24844976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and management of patients with Boston type 1 keratoprosthesis explantation--the University of Montreal Hospital Center experience.
    Wang Q; Harissi-Dagher M
    Am J Ophthalmol; 2014 Dec; 158(6):1297-1304.e1. PubMed ID: 25174898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined surgical management of capsular and iris deficiency with glued intraocular lens technique.
    Kumar DA; Agarwal A; Jacob S; Lamba M; Packialakshmi S; Meduri A
    J Refract Surg; 2013 May; 29(5):342-7. PubMed ID: 23659232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications associated with clear corneal cataract wounds during vitrectomy.
    Wong RW; Kokame GT; Mahmoud TH; Mieler WF; Tornambe PE; McDonald HR
    Retina; 2010 Jun; 30(6):850-5. PubMed ID: 20090563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.
    Shah KJ; Cheung AY; Holland EJ
    Cornea; 2018 Jan; 37(1):11-14. PubMed ID: 28990998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Black diaphragm intraocular lens implantation in aphakic eyes with traumatic aniridia and previous pars plana vitrectomy.
    Dong X; Yu B; Xie L
    J Cataract Refract Surg; 2003 Nov; 29(11):2168-73. PubMed ID: 14670427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of aniridia with Boston type I keratoprosthesis.
    Rixen JJ; Cohen AW; Kitzmann AS; Wagoner MD; Goins KM
    Cornea; 2013 Jul; 32(7):947-50. PubMed ID: 23449480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious keratitis after Boston type 1 keratoprosthesis implantation.
    Chan CC; Holland EJ
    Cornea; 2012 Oct; 31(10):1128-34. PubMed ID: 22960647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K; Yu F; Aldave AJ
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Black diaphragm intraocular lens for congenital aniridia or traumatic iris deficiency].
    Yang J; Lu Y; Luo Y; Wang JJ
    Zhonghua Yan Ke Za Zhi; 2004 Sep; 40(9):605-8. PubMed ID: 15500765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhegmatogenous retinal detachment in phakic eyes after posterior chamber phakic intraocular lens implantation for severe myopia.
    Martínez-Castillo V; Boixadera A; Verdugo A; Elíes D; Coret A; García-Arumí J
    Ophthalmology; 2005 Apr; 112(4):580-5. PubMed ID: 15808247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual and clinical outcomes of explantation versus preservation of the intraocular lens during keratoprosthesis implantation.
    Utine CA; Tzu J; Dunlap K; Akpek EK
    J Cataract Refract Surg; 2011 Sep; 37(9):1615-22. PubMed ID: 21855761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glaucoma Management in Patients With Aniridia and Boston Type 1 Keratoprosthesis.
    Nascimento E Silva R; Shen LQ; Chiou CA; Shanbhag SS; Paschalis EI; Pasquale LR; Colby KA; Dohlman CH; Chodosh J; Alves MR
    Am J Ophthalmol; 2019 Nov; 207():258-267. PubMed ID: 31247168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Boston keratoprosthesis in Stevens-Johnson syndrome.
    Sayegh RR; Ang LP; Foster CS; Dohlman CH
    Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.